No Detail Found!

Frequency and Risk Factors of Lipohypertrophy in Insulin Treated Patients with Diabetes: An Experience from a Tertiary Care Center in Multan

Author(s)
Mehwish Saeed Department of Medicine and Endocrinology, Nishtar Hospital, Multan.Pakistan
Wasif Aslam Department of Medicine, Nishtar Hospital, Multan.Pakistan
Muddasar Ahmad Department of Medicine, Nishtar Hospital, Multan.Pakistan
Muhammad Nadeem Sohail Department of Medicine and Endocrinology, Nishtar Hospital, Multan.Pakistan
Aliya Akhtar Department of Dermatology, Nishtar Hospital, Multan.Pakistan
Hammad Zafar Department of Medicine, Services Hospital, Lahore.Pakistan
Abstract
Objective: The present study aimed to evaluate the frequency and risk factors of lipohypertrophy in insulin treated patients in a tertiary care center in Multan. Study Design: cross sectional descriptive study Place and Duration of Study: This study was conducted at the Diabetic Outdoor of Nishtar Hospital, Multan between 1st January 2022 to 31st June 2022. Materials and Methods: We included 360 patients, taking insulin for more than one year in our study. The patients were interviewed about insulin injection habits and the injection sites examined according to a preformed questionnaire. Results: We included 360 patients with diabetes mellitus who used insulin for more than one year. The frequency of lipohypertrophy was 43.6%. Mean duration of diabetes and mean duration of insulin use were 14.68±7.62 years and 8.45±6.1 years, respectively. Longer disease duration, longer insulin use, higher doses, use of ice cold insulin and lack of rotation of injection site were the major risk factors of lipohypertrophy. Conclusion: Lipohypertrophy is a common complication of insulin use related largely to improper injection technique. Patient education and frequent examination of the injection site can help prevent lipohypertrophy.
Publication Details
Page(s) 78-82
DOI DOI not available
Published Journal: Medical Forum, Volume: 33, Issue: 8, Year: 2022

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Insulin, Injection Site, lipohypertrophhy
0

Citations

0

Downloads

85

Views